Source:http://linkedlifedata.com/resource/pubmed/id/19607915
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2009-9-28
|
pubmed:abstractText |
beta-galactosidase (GLB1) forms a functional lysosomal multienzyme complex with lysosomal protective protein (PPCA) and neuraminidase 1 (NEU1) which is important for its intracellular processing and activity. Mutations in the beta-galactosidase gene cause the lysosomal storage disease G(M1)-gangliosidosis. In order to identify additional molecular changes associated with the presence of beta-galactosidase mutations, the expression of canine lysosomal multienzyme complex components in GLB1(+/+), GLB1(+/-) and GLB1(-/-) fibroblasts was investigated by quantitative RT-PCR, Western blot and enzymatic assays. Quantitative RT-PCR revealed differential regulation of total beta-galactosidase, beta-galactosidase variants and protective protein for beta-galactosidase gene (PPGB) in GLB1(+/-) and GLB1(-/-) compared to GLB1(+/+) fibroblasts. Furthermore, it was shown that PPGB levels gradually increased with the number of mutant beta-galactosidase alleles while no change in the NEU1 expression was observed. This is the first study that simultaneously examine the effect of GLB1(+/+), GLB1(+/-) and GLB1(-/-) genotypes on the expression of lysosomal multienzyme complex components. The findings reveal a possible adaptive process in GLB1 homozygous mutant and heterozygous individuals that could facilitate the design of efficient therapeutic strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cathepsin A,
http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/Neuraminidase,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Galactosidase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1792
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
982-7
|
pubmed:meshHeading |
pubmed-meshheading:19607915-Animals,
pubmed-meshheading:19607915-Cathepsin A,
pubmed-meshheading:19607915-Dogs,
pubmed-meshheading:19607915-Fibroblasts,
pubmed-meshheading:19607915-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:19607915-Lysosomes,
pubmed-meshheading:19607915-Multienzyme Complexes,
pubmed-meshheading:19607915-Mutation,
pubmed-meshheading:19607915-Neuraminidase,
pubmed-meshheading:19607915-RNA, Messenger,
pubmed-meshheading:19607915-beta-Galactosidase
|
pubmed:year |
2009
|
pubmed:articleTitle |
Impact of beta-galactosidase mutations on the expression of the canine lysosomal multienzyme complex.
|
pubmed:affiliation |
Department of Pathology, University of Veterinary Medicine, Hannover, Bünteweg 17, D-30559, Hannover, Germany. robert.kreutzer@tiho-hannover.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|